Riskpilot← Back to searchSign inGet full accessCURARE II AS
ASActiveOrg 920566901Hieronymus Heyerdahls Gate 1, 0160 OsloEconomic activity was not specified by tax authority · NACE 0000Est. 20180 employees
Revenue 2024
NOK 5,6M
EBITDA margin
96.2%
+2942% vs 2023
Equity ratio
43.1%
Financial strength
Net profit 2024
NOK 515K
+421% vs 2023
| Revenue | NOK 5,6M | — |
| EBITDA | NOK 5,4M | +2942% |
| Net profit | NOK 515K | +421% |
| Total assets | NOK 1,4M | -75% |
| Equity | NOK 616K | -89% |
| Employees | 0 | — |
Legal name
CURARE II AS
Org number
920566901
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
8. mars 2018
Share capital
NOK 100 580
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Investere i verdipapirer og andre formuesobjekter, herunder deltakelse i andre selskaper med lignende virksomhet.
Address
Hieronymus Heyerdahls Gate 1, 0160 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 10 307 | 0 | 0 | 5 581 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −138 | 10 101 | −191 | −189 | 5 368 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −138 | 10 101 | −191 | −189 | 5 368 |
| Net financials | −12 | −167 | 799 | 28 | −4 083 |
| Profit before tax | −150 | 9 934 | 608 | −161 | 1 285 |
| Tax | −0 | 2 722 | 135 | −0 | 770 |
| Net profit | −150 | 7 212 | 473 | −161 | 515 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 868 | 10 746 | 6 093 | 5 757 | 1 428 |
| Equity | 796 | 5 432 | 5 905 | 5 744 | 616 |
| Long-term debt | 540 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 532 | 5 315 | 188 | 13 | 812 |
| Total debt | 9 072 | 5 315 | 188 | 13 | 812 |
EBITDA margin
96.2%
This company
15.8%
Market median
+509% vs market
20202024
Equity ratio
43.1%
This company
38.2%
Market median
+13% vs market
20202024
Return on equity
83.7%
This company
18.4%
Market median
+355% vs market
20202024
Net profit margin
9.2%
This company
8.1%
Market median
+14% vs market
20202024
Asset turnover
3.91×
This company
1.12×
Market median
+249% vs market
20202024
Debt / equity
1.32×
This company
0.62×
Market median
-113% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
| Chairman | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 42.55% | 42.55% | 2024 | |
| Company | 42.55% | 42.55% | 2024 | |
| Company | 7.45% | 7.45% | 2024 | |
| Company | 5.32% | 5.32% | 2024 | |
| Company | 2.13% | 2.13% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gaius As
CURARE II AS Board members of CURARE II AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Gudmund Frøseth | Board of Directors | 0 companies |
| Gudleik Njå | Board of Directors | 0 companies |
| Marius Juul Møller | Chairman | 0 companies |